Table 2.
Enrollment Examination Between the Groups
| Parameters | PVR Group | Medication Group | P Value |
|---|---|---|---|
| CMR | |||
| PRF, % | 37.73±8.22 | 39.02±7.91 | 0.367 |
| Corrected RV EF, % | 20.71±5.43 | 22.97±5.63 | 0.070 |
| LV EF, % | 47.88±7.93 | 46.88±10.26 | 0.869 |
| RV EDVI, mL/m2 | 157.87±40.39 | 155.70 (72.10) | 0.702 |
| RV ESVI, mL/m2 | 104.43±34.00 | 90.65 (65.60) | 0.824 |
| RV EDD, mm | 43.38±8.33 | 44.74±8.56 | 0.721 |
| TTE | |||
| LV EF, % | 60.0 (10.9) | 60.26±9.29 | 0.650 |
| RV EDD, mm | 41.82±6.64 | 40.26±8.31 | 0.417 |
| TR | 2.15±1.27 | 2.47±1.62 | 0.354 |
| ECG | |||
| QRS duration, ms | 139.24±30.41 | 147.03±30.04 | 0.260 |
| Chest x‐ray | |||
| Cardiothoracic ratio | 0.57±0.07 | 0.57±0.08 | 0.572 |
CMR indicates cardiac magnetic resonance; EDD, end‐diastolic diameter; EDVI, end‐diastolic volume index; EF, ejection fraction; ESVI, end‐systolic volume index; LV, left ventricular; PRF, pulmonary regurgitation fraction; RV, right ventricular; TR, tricuspid regurgitation; TTE, transthoracic echocardiography.